Class information for:
Level 2: CLOPIDOGREL//PRASUGREL//ASPIRIN RESISTANCE

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
202 20434 36.3 72%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 3)


ID, lev.
above		 Publications Label for level above
189 51017 CLOPIDOGREL//PLATELETS//PRASUGREL

Classes in level below (level 1)


ID, lev. below Publications Label for level below
418 3425 CLOPIDOGREL//PRASUGREL//TICAGRELOR
3069 1992 GLANZMANN THROMBASTHENIA//GLANZMANNS THROMBASTHENIA//THROMBASTHENIA
4493 1702 GLYCOPROTEIN VI//GPVI//CLEC 2
5795 1506 HUMAN PLATELET//PLATELETS HUMAN//ATPASE CA2 MG2
7379 1295 BERNARD SOULIER SYNDROME//MAY HEGGLIN ANOMALY//EPSTEIN SYNDROME
7850 1243 ASPIRIN RESISTANCE//PFA 100//THROMBOSTAT
9410 1089 MEAN PLATELET VOLUME//PLATELET DISTRIBUTION WIDTH//PLATELET INDICES
9536 1079 PLATELET PROTEOME//EFS AUVERGNE LOIRE//SECT CARDIOIMMUNOL
11244 930 9 ALLYLPURINES//ANTIPLATELET COMPOUNDS//HAMILTON GEN HOSP CLIN UNIT
11445 914 DIABETOL DDG//JOHN COOK RENAL UNIT//PLATELET HYPERSENSITIVITY
16059 608 DERMCIDIN ISOFORM 2//ACUTE ISCHEMIC HEART DISEASE//GEA 3175
16168 602 COAGULATION ABNORMALITY//D L LYSINACETYLSALICYLATE//SECT CLIN GERONTOL VASC MED
16477 586 RECEPTOR C K//PLATELET THROMBOXANE FORMATION//REFLECTION CONTRAST MICROSCOPY
18023 508 PLATELET PMN INTERACTION//ATHLETIC HORSE//B TG
18794 470 ACT STUDY//ASPIRIN DOSE//ANTIOXIDANT DEFENSE MECHANISM
21210 369 SPONTANEOUS PLATELET AGGREGATION//PARTICLE COUNTING METHOD//AGGREGOMETER
21469 359 TICLOPIDINE//TICLOPIDINE HYDROCHLORIDE//PCA 4230
22108 336 CORONARY ARTERIAL TONE//VASC BIOL MED ERFURT//PLATELET NEUTROPHIL INTERACTION
24688 254 CARANE DERIVATIVES//AII RECEPTORS//BLOOD PLATELET
25066 243 VESSEL WALL INJURY//INTERDISCIPLINARY EXCELLENCE PROGRAM HLTH AGI//CLIN BIOCHEM IMMUNOHEMATOL
28195 173 PRIMA CLIN MED//BIOMED EVOLUT AGING//CLIN LIPID
28786 162 PLATELET APOPTOSIS//COATED PLATELET//STUDY HUMAN OPERATOR PERFORMANCE
30791 133 INDOBUFEN//INDOBUFEN ENANTIOMERS//ATHEROSCLEROSIS PERIPHERAL
31011 129 RESPIRATION PHOSPHORYLATION COUPLING//CLIN PHARMACOL CLIN NEUROSCI//MOUSE PLATELETS
31829 117 NIPECOTAMIDES//ALPHA THROMBIN BINDING//CYTOSOLIC CA2 INCREASE
32126 112 ENDOTHELAEMIA//INTERDISCIPLINARY ONCOLEXPT THER EUT PROGR//ENDOTHELEMIA
33063 98 TRIFLUSAL//HTB//CAS 322 79 2

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class
1 CLOPIDOGREL Author keyword 1184 58% 7% 1366
2 PRASUGREL Author keyword 550 78% 2% 359
3 ASPIRIN RESISTANCE Author keyword 516 89% 1% 234
4 PLATELETS Author keyword 502 23% 9% 1904
5 MEAN PLATELET VOLUME Author keyword 483 70% 2% 401
6 TICAGRELOR Author keyword 369 76% 1% 262
7 PLATELET AGGREGATION Author keyword 221 25% 4% 768
8 PLATELET Author keyword 205 23% 4% 792
9 PLATELET REACTIVITY Author keyword 184 68% 1% 163
10 ASPIRIN Author keyword 180 18% 5% 931

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class		 LCSH search Wikipedia search
1 CLOPIDOGREL 1184 58% 7% 1366 Search CLOPIDOGREL Search CLOPIDOGREL
2 PRASUGREL 550 78% 2% 359 Search PRASUGREL Search PRASUGREL
3 ASPIRIN RESISTANCE 516 89% 1% 234 Search ASPIRIN+RESISTANCE Search ASPIRIN+RESISTANCE
4 PLATELETS 502 23% 9% 1904 Search PLATELETS Search PLATELETS
5 MEAN PLATELET VOLUME 483 70% 2% 401 Search MEAN+PLATELET+VOLUME Search MEAN+PLATELET+VOLUME
6 TICAGRELOR 369 76% 1% 262 Search TICAGRELOR Search TICAGRELOR
7 PLATELET AGGREGATION 221 25% 4% 768 Search PLATELET+AGGREGATION Search PLATELET+AGGREGATION
8 PLATELET 205 23% 4% 792 Search PLATELET Search PLATELET
9 PLATELET REACTIVITY 184 68% 1% 163 Search PLATELET+REACTIVITY Search PLATELET+REACTIVITY
10 ASPIRIN 180 18% 5% 931 Search ASPIRIN Search ASPIRIN

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ANTIPLATELET THERAPY 477 38% 5% 982
2 STENT THROMBOSIS 376 65% 2% 356
3 ASPIRIN TREATED PATIENTS 360 96% 1% 108
4 CLOPIDOGREL 313 28% 5% 970
5 ASPIRIN RESISTANCE 297 65% 1% 280
6 OF CARE ASSAY 292 88% 1% 136
7 OF FUNCTION POLYMORPHISM 279 78% 1% 182
8 PLATELET REACTIVITY 275 58% 2% 315
9 ADENOSINE DIPHOSPHATE 255 58% 1% 291
10 BERNARD SOULIER SYNDROME 240 66% 1% 220

Journals


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class
1 PLATELETS 371 43% 3% 665
2 THROMBOSIS RESEARCH 177 13% 6% 1263
3 THROMBOSIS AND HAEMOSTASIS 119 11% 5% 1036
4 JOURNAL OF THROMBOSIS AND HAEMOSTASIS 56 12% 2% 435
5 HAMOSTASEOLOGIE 4 10% 0% 39
6 PROSTAGLANDINS AND MEDICINE 3 11% 0% 26

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Novel antiplatelet agents in acute coronary syndrome 2015 8 153 74%
Consensus and Update on the Definition of On-Treatment Platelet Reactivity to Adenosine Diphosphate Associated With Ischemia and Bleeding 2013 76 73 89%
Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI A Meta-analysis 2010 345 35 86%
Mean Platelet Volume: A Link Between Thrombosis and Inflammation? 2011 272 147 80%
Effect of Aspirin on Vascular and Nonvascular Outcomes Meta-analysis of Randomized Controlled Trials 2012 109 39 67%
Platelet-collagen interaction: is GPVI the central receptor? 2003 486 137 82%
CYP2C19 Genotype, Clopidogrel Metabolism, Platelet Function, and Cardiovascular Events A Systematic Review and Meta-analysis 2011 181 50 64%
Conflicting Results Between Randomized Trials and Observational Studies on the Impact of Proton Pump Inhibitors on Cardiovascular Events When Coadministered With Dual Antiplatelet Therapy Systematic Review 2015 2 42 98%
Mechanisms of disease: Platelet activation and atherothrombosis 2007 676 105 41%
Platelets as Cellular Effectors of Inflammation in Vascular Diseases 2013 53 157 61%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 SINAI THROMBOSIS 47 64% 0.2% 46
2 AUSTRALIAN BLOOD DIS 41 34% 0.5% 97
3 HEARTDRUG S 33 64% 0.2% 32
4 E348 24 91% 0.0% 10
5 UNITA MED 3 23 76% 0.1% 16
6 TIMI STUDY GRP 23 21% 0.5% 95
7 MED JACKSONVILLE 22 29% 0.3% 64
8 PLATELET FUNCT STUDIES 22 45% 0.2% 37
9 SOL SHERRY THROMBOSIS 22 22% 0.4% 86
10 ST ANTONIUS PLATELET FUNCT 21 85% 0.1% 11

Related classes at same level (level 2)


Rank Relatedness score Related classes
1 0.0000013539 I EM NEURODEGENERAT BRAIN//BERAPROST SODIUM//IBUDILAST
2 0.0000013351 CILOSTAZOL//CLIN PHARMACOKINET PHARMACODYNAM METAB//AZECINES
3 0.0000011488 IMMUNE THROMBOCYTOPENIA//IDIOPATHIC THROMBOCYTOPENIC PURPURA//IMMUNE THROMBOCYTOPENIC PURPURA
4 0.0000011334 DYSFIBRINOGENEMIA//AFIBRINOGENEMIA//DYSFIBRINOGEN
5 0.0000009180 EXOSOMES//MICROVESICLES//EXTRACELLULAR VESICLES
6 0.0000008946 HAEMOPHILIA//HAEMOPHILIA A//VON WILLEBRAND DISEASE
7 0.0000008102 E SELECTIN//SELECTIN//ICAM 1
8 0.0000008048 GLASGOW PROGNOSTIC SCORE//NEUTROPHIL TO LYMPHOCYTE RATIO//NEUTROPHIL LYMPHOCYTE RATIO
9 0.0000007743 PERCUTANEOUS CORONARY INTERVENTION//DRUG ELUTING STENT//CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
10 0.0000007390 P2X7 RECEPTOR//P2X7//NTPDASE